Haiping Zhang1,
Zhiying Wu2,
Nanhuo Han1,
Lu Xu3,
Kai Xiong1
For correspondence:- Kai Xiong Email: cnrj92@163.com
Accepted: 28 September 2019 Published: 31 October 2019
Citation: Zhang H, Wu Z, Han N, Xu L, Xiong K. Dexmedetomidine pretreatment alleviates ischemia-reperfusion injury-induced inflammatory reaction via inhibition of TLR-4/NF-κB signaling pathway. Trop J Pharm Res 2019; 18(10):2031-2035 doi: 10.4314/tjpr.v18i10.5
© 2019 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..
Archives
News Updates